1 option
Clinical review report : indication: chronic fibrosing interstitial lung diseases. Nintedanib (Ofev) (Boehringer Ingelheim Canada Ltd.) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Language:
- English
- Subjects (All):
- Outcome assessment (Medical care).
- Physical Description:
- 1 online resource (65 pages)
- Place of Publication:
- Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2021.
- Summary:
- The objective of this review is to perform a systematic review of the beneficial and harmful effects of nintedanib for patients with chronic fibrosing interstitial lung disease with a progressive phenotype.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.